Literature DB >> 13358612

Prevention of coronary and cerebral thrombosis.

L L CRAVEN.   

Abstract

Entities:  

Keywords:  ACETYLSALICYLIC ACID/therapeutic use; BISHYDROXYCOUMARIN/therapeutic use; CEREBRAL EMBOLISM AND THROMBOSIS/prevention and control; CORONARY DISEASE/prevention and control

Mesh：

Substances：

Year:  1956        PMID： 13358612

Source DB:  PubMed          Journal:  Miss Valley Med J        ISSN： 0096-5480


× No keyword cloud information.
  18 in total

1.  The Emergence of Thrombocardiology.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

Review 2.  The current role of platelet-active drugs in ischaemic heart disease.

Authors:  D M Kerins; G A FitzGerald
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

3.  The early clinical history of salicylates in rheumatology and pain.

Authors:  T Hedner; B Everts
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

4.  Aspirin for reducing cancer metastases?

Authors:  U K Henschke; G J Luande; J D Choppala
Journal:  J Natl Med Assoc       Date:  1977-08       Impact factor: 1.798

Review 5.  Clinical research of traditional Chinese medicine in big data era.

Authors:  Junhua Zhang; Boli Zhang
Journal:  Front Med       Date:  2014-09-13       Impact factor: 4.592

Review 6.  Platelets, aspirin, and cardiovascular disease.

Authors:  P C Elwood; C Hughes; J R O'Brien
Journal:  Postgrad Med J       Date:  1998-10       Impact factor: 2.401

7.  Antiplatelet therapy for prevention of recurrent stroke.

Authors:  Aamir Badruddin; Philip B Gorelick
Journal:  Curr Treat Options Neurol       Date:  2009-11       Impact factor: 3.598

8.  An intervention study-the aspirin myocardial infarction study.

Authors: 
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

9.  A history of streptokinase use in acute myocardial infarction.

Authors:  Nikhil Sikri; Amit Bardia
Journal:  Tex Heart Inst J       Date:  2007

Review 10.  Multifunctional actions of approved and candidate stroke drugs.

Authors:  Jens Minnerup; Wolf-Rüdiger Schäbitz
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.